Year: 2019
Type: review
Abstract: Cognitive impairments reported across psychiatric conditions (ie, major depressive disorder, bipolar disorder, schizophrenia, and posttraumatic stress disorder) strongly impair the quality of life of patients and the recovery of those conditions. There is therefore a great need for consideration for cognitive dysfunction in the management of psychiatric disorders. The redundant pattern of cognitive impairments across such conditions suggests possible shared mechanisms potentially leading to their development. Here, we review for the first time the possible role of inflammation in cognitive dysfunctions across psychiatric disorders. Raised inflammatory processes (microglia activation and elevated cytokine levels) across diagnoses could therefore disrupt neurobiological mechanisms regulating cognition, including Hebbian and homeostatic plasticity, neurogenesis, neurotrophic factor, the HPA axis, and the kynurenine pathway. This redundant association between elevated inflammation and cognitive alterations across psychiatric disorders hence suggests that a cross-disorder approach using pharmacological and nonpharmacological (ie, physical activity and nutrition) anti-inflammatory/immunomodulatory strategies should be considered in the management of cognition in psychiatry.
Source: CNS Spectrums
Institutions: The University of Adelaide, The University of Melbourne
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Keywords: neuroinflammation, cognitive impairment, mental illness, major depressive disorder, bipolar disorder, schizophrenia, post-traumatic stress disorder, microglial activation, cytokines, synaptic plasticity, neurogenesis, neurotrophic factors, hypothalamic-pituitary-adrenal axis, kynurenine pathway, anti-inflammatory therapy, immunomodulation, physical activity, nutrition
Open Access status: bronze
Funder: Fay Fuller Foundation
OpenAlex ID: W2911384921
